Kennedy Halts $500M in BARDA mRNA Vaccine Projects

In a move that has stirred internal disruption at a crucial federal health agency and reignited debate over the future of messenger RNA technology, Health and Human Services Secretary Robert F. Kennedy Jr. announced the termination of about 500 million in 22 BARDA-funded mRNA vaccine development projects. The decision, framed by Kennedy as a reallocation to safer, more proven platforms, came with little advance notice and has been greeted with concern from scientists, clinicians, and public health advocates who say it could slow innovations with potential to prevent and treat a wide range of diseases.

Kennedy’s announcement underscored a broader tension inside the administration over how to balance rapid scientific advancement with perceived safety and public trust. In explaining the policy shift, Kennedy asserted that the data show current mRNA vaccine investments do not provide adequate protection against upper respiratory infections such as COVID-19 and flu. He said resources would be redirected to approaches with stronger safety records and transparent data practices. The decision, however, was widely interpreted as part of a broader critique of mRNA technology itself and...